A CCR5-Dependent Novel Mechanism for Type 1 HIV gp120 Induced Loss of Macrophage Cell Surface CD41

Type 1 HIV gp120 is especially effective in disrupting immune cell function because it is able to cause dysregulation of both infected and uninfected cells. We report a novel CCR5-dependent mechanism of gp120-induced CD4 loss from macrophages. An M-tropic gp120, using CCR5, is able to induce 70% loss of cell surface CD4 from macrophages within an hour. This cell surface CD4 loss is more substantial and rapid than the 20% loss observed with T-tropic gp120IIIB by 3 h. The rapid and substantial CD4 loss induced by M-tropic gp120 is not observed on macrophages homozygous for the ccr5Δ32 mutation, which fail to express cell surface CCR5. We have used confocal imaging to show that gp120 and CD4 are internalized together by a process resembling receptor-mediated endocytosis, and that both proteins enter HLA-DR containing compartments of the macrophage. We have also shown by semiquantitative RT-PCR that, in response to CD4 loss from the cell surface, mRNA for CD4 is up-regulated and the intracellular pool of CD4 increases. CCR5 mRNA levels are also increased. It is proposed that internalization of self and viral protein and increased pools of intracellular CD4 could modulate Ag presentation efficiencies and have implications for the induction and maintenance of both productive immune responses and self-tolerance.

[1]  C. Broder,et al.  Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. , 2000, Experimental and molecular pathology.

[2]  S. Howie,et al.  Interactions of HIV‐1 with antigen‐presenting cells , 1999, Immunology and cell biology.

[3]  G. Trinchieri,et al.  The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. , 1999, Blood.

[4]  Q. Sattentau,et al.  Constitutive cell surface association between CD4 and CCR5. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  James E. K. Hildreth,et al.  T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. , 1999, Journal of immunology.

[6]  D. Missé,et al.  A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. , 1999, Blood.

[7]  D. Harrison,et al.  A functional, discontinuous HIV‐1 gp120 C3/C4 domain‐derived, branched, synthetic peptide that binds to CD4 and inhibits MIP‐1α chemokine binding , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  S. Fidler,et al.  Antigen presenting cell function in HIV-1 infected patients. , 1999, Immunology letters.

[9]  T L Hoffman,et al.  HIV-1 envelope determinants for cell tropism and chemokine receptor use. , 1999, Molecular membrane biology.

[10]  H. Choe Chemokine receptors in HIV-1 and SIV infection , 1998, Archives of pharmacal research.

[11]  M. Zouali,et al.  Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  F. Peter HIV nef: the mother of all evil? , 1998, Immunity.

[13]  Ying Sun,et al.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. , 1998, Science.

[14]  D. Gajdusek,et al.  Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcgamma receptors and expression of monokines. , 1998, Blood.

[15]  A. Benner,et al.  Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus Type 1 (HIV-1)-infected children , 1998, Cell Death and Differentiation.

[16]  V. Barnaba,et al.  Autoimmune T-cell response to the CD4 molecule in HIV-infected patients. , 1998, Viral immunology.

[17]  J. Hoxie,et al.  Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1 , 1997, Journal of virology.

[18]  L. Lopalco,et al.  Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects. , 1997, AIDS research and human retroviruses.

[19]  O. Kutsch,et al.  Rapid and selective depletion of CD4+ T lymphocytes and preferential loss of memory cells on interaction of mononuclear cells with HIV-1 glycoprotein-expressing cells. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[20]  N. Chirmule,et al.  CD4 cross-linking (CD4XL) induces RAS activation and tumor necrosis factor-alpha secretion in CD4+ T cells. , 1997, Blood.

[21]  H. Hashimoto,et al.  Role of tumour necrosis factor‐alpha (TNF‐α) in the induction of HIV‐1 gp120‐mediated CD4+ T cell anergy , 1997, Clinical and experimental immunology.

[22]  C. Pitcher,et al.  CD4: a co-receptor in the immune response and HIV infection. , 1997, The international journal of biochemistry & cell biology.

[23]  T. Coyle Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1997, The Medical clinics of North America.

[24]  N. Ampel,et al.  Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: epitope analysis and time course. , 1997, Clinical immunology and immunopathology.

[25]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[26]  W. Cruikshank,et al.  Interleukin 16 and its function as a CD4 ligand. , 1996, Immunology today.

[27]  Newell,et al.  Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Fine,et al.  CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. , 1996, Journal of immunology.

[29]  N. Chirmule,et al.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. , 1996, Microbiological reviews.

[30]  V. Karsten,et al.  HIV‐1 envelope glycoprotein gp120 down‐regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor‐α , 1996, Immunology.

[31]  L. Montaner,et al.  Lipopolysaccharide (LPS) down‐regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL‐1β , 1995, Clinical and experimental immunology.

[32]  A. Smolyar,et al.  Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I. Blanca,et al.  Decreased T-cell proliferative response to common environmental antigens could be an indicator of early human immunodeficiency virus-mediated lymphocyte lesions , 1995, Clinical and diagnostic laboratory immunology.

[34]  Fauci As AIDS: newer concepts in the immunopathogenic mechanisms of human immunodeficiency virus disease. , 1995 .

[35]  J. Sodroski,et al.  Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein , 1995, Journal of virology.

[36]  A. Fauci AIDS: newer concepts in the immunopathogenic mechanisms of human immunodeficiency virus disease. , 1995, Proceedings of the Association of American Physicians.

[37]  A. Theodore,et al.  CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. , 1994, Journal of acquired immune deficiency syndromes.

[38]  S. Rhee,et al.  Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4 , 1994, Journal of Virology.

[39]  P. Ebbesen,et al.  Antibody‐dependent enhancement of HIV‐1 infection in human term syncytiotrophoblast cells cultured in vitro , 1994, Clinical and experimental immunology.

[40]  M. Ernst,et al.  HIV‐1 envelope protein gp120 affects phenotype and function of monocytes in vitro , 1994, Journal of leukocyte biology.

[41]  F. Belardelli,et al.  Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication , 1994, Journal of virology.

[42]  M. Martin,et al.  Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 , 1992, Journal of virology.

[43]  S. Levitz,et al.  HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans. , 1992, The American review of respiratory disease.

[44]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[45]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[46]  D. Littman,et al.  The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits , 1992, The Journal of cell biology.

[47]  W. Cruikshank,et al.  Identification of HIV‐1 Envelope Glycoprotein in the Serum of AIDS and ARC Patients , 1992, Journal of acquired immune deficiency syndromes.

[48]  M. Waugh,et al.  Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. , 1990, Blood.

[49]  L. Arthur,et al.  HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. , 1989, Journal of immunology.

[50]  M. Reitz,et al.  Envelope sequences of two new United States HIV-1 isolates. , 1988, Virology.

[51]  F. Barré-Sinoussi HIV target cells: effect of their infection by HIV on the pathogenesis of AIDS. , 1988, Lymphology.

[52]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.